High-risk factors for massive haemorrhage in medical abortion patients with missed miscarriage.
Tan Y, Li S, Xu H, Wang S.
BMC Pregnancy Childbirth. 2024 Sep 9;24(1):521. doi: 10.1186/s12884-024-06682-x.
[Medical abortion provided by telemedicine to women in Latin America: complications and their treatment].
Larrea S, Palència L, Perez G.
Gac Sanit. 2015 May-Jun;29(3):198-204. doi: 10.1016/j.gaceta.2015.02.003. Epub 2015 Mar 12.
Medical abortion offered in pharmacy versus clinic-based settings: A systematic review.
Rodriguez MI, Edelman AB, Hersh A, Gartoulla P, Henderson JT.
Contraception. 2021 Nov;104(5):478-483. doi: 10.1016/j.contraception.2021.06.014. Epub 2021 Jun 24.
Midtrimester abortion.
Hern WM.
Obstet Gynecol Annu. 1981;10:375-422.
Abortion services during the COVID-19 pandemic: a systematic review.
Qaderi K, Khodavirdilou R, Kalhor M, Behbahani BM, Keshavarz M, Bashtian MH, Dabir M, Irani M, Manouchehri E, Farahani MF, Mallah MA, Shamsabadi A.
Reprod Health. 2023 Apr 13;20(1):61. doi: 10.1186/s12978-023-01582-3.
Medical abortion offered in pharmacy versus clinic-based settings.
Rodriguez MI, Edelman A, Hersh A, Gartoulla P, Henderson J.
Cochrane Database Syst Rev. 2021 Jun 11;6(6):CD013566. doi: 10.1002/14651858.CD013566.pub2.
No-Test Medication Abortion: A Systematic Review.
Pearlman Shapiro M, Dethier D, Kahili-Heede M, Kaneshiro B.
Obstet Gynecol. 2023 Jan 1;141(1):23-34. doi: 10.1097/AOG.0000000000005016. Epub 2022 Dec 5.
Methods for induced abortion.
Stubblefield PG, Carr-Ellis S, Borgatta L.
Obstet Gynecol. 2004 Jul;104(1):174-85. doi: 10.1097/01.AOG.0000130842.21897.53.
Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
Gemzell-Danielsson K, Lalitkumar S.
Reprod Health Matters. 2008 May;16(31 Suppl):162-72. doi: 10.1016/S0968-8080(08)31371-8.
[Complications of termination of pregnancy].
Faucher P.
J Gynecol Obstet Biol Reprod (Paris). 2016 Dec;45(10):1536-1551. doi: 10.1016/j.jgyn.2016.09.016. Epub 2016 Nov 3.
